Liquidity (Details) (USD $)	3 Months Ended	12 Months Ended
	Sep. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011	Jun. 28, 2013	Sep. 06, 2011	Jun. 30, 2010	Sep. 06, 2012 Scenario, Forecast [Member]
Cash and cash equivalents		$ 2,290,000	$ 1,899,000	$ 3,061,000			$ 5,702,000
Net losses		(4,292,000)	(4,695,000)	(3,733,000)
Accumulated deficit		(119,018,000)	(114,726,000)
Licensing fee paid						500,000
Total initial licensing fee						1,000,000
Amount owed for current outstanding Prostiva liabilities prior to Restructuring Agreement								500,000
Amount of liabilities restructured					7,500,000
Cash paid related to Restructuring Agreement.		2,000,000
Promissory note payable		5,300,000
Promissory note, interest rate		6.00%
Gain on debt extinguishment		206,000
Shares of common stock sold	5,980,000
Shares price of common stock sold	$ 0.75
Net proceeds from secondary offering		3,814,000
Line of credit, initiation date		Jan. 11, 2012
Line of credit, maximum borrowing capacity		$ 2,000,000
Percentage of eligible accounts receivable used for defined borrowing of line of credit		80.00%